Host: The Japanese Pharmacological Society
Name : The 97th Annual Meeting of the Japanese Pharmacological Society
Number : 97
Location : [in Japanese]
Date : December 14, 2023 - December 16, 2023
SARS-CoV-2, the causative agent of COVID-19, emerged at the end of 2019. During its global spread over the past 3 years, SARS-CoV-2 has been highly diversified, and these SARS-CoV-2 variants have been considered to be the potential threats to the human society. In order to elucidate the virological characteristics of newly emerging SARS-CoV-2 variants in real-time, I launched a consortium called “The Genotype to Phenotype Japan (G2P-Japan)” in January 2021. With the colleagues who joined the G2P-Japan consortium, we have revealed the virological characteristics of SARS-CoV-2 variants. In May 2023, WHO declared the end of the Public Health Emergency of International Concern (PHEIC) for COVID-19. However, “the next pandemic” will come in the future, and we need to gather our wisdom learned from the COVID-19 pandemic for the preparedness of future pandemic. Here, I will talk about our findings on SARS-CoV-2 variants and future perspectives to combat the outbreaks and pandemic that will happen in the future.
